Celltrion Takes Trio Of GGB Awards In Milan
As Sandoz And Dr Reddy’s Also Take Home Two Awards Each
Executive Summary
Celltrion has taken home three awards while Sandoz and Dr Reddy’s have walked away with two prizes each, after winners were announced at the Global Generics & Biosimilars Awards 2021, held in Milan, Italy, on 10 November.
You may also be interested in...
Eurofarma Biosimilars Deal Broadens Access To Latin America For Henlius
Shanghai Henlius Biotech has announced a licensing deal for three biosimilars – bevacizumab, rituximab and trastuzumab – with Brazil’s Eurofarma. The agreement, which could be worth as much as $50.5m, gives the Chinese company enhanced access to Latin America as it continues to broaden its global footprint.
Generics Bulletin Editor’s Picks For Q4 2021
As 2021 drew to a close, there was no shortage of exciting developments for the off-patent industry. Alongside news of a strategic review affecting one of the biggest generics and biosimilars players, Generics Bulletin also held its annual Global Generics & Biosimilars Awards and brought readers fresh and exclusive insights from top industry executives.
IHP Will Double Donations In Early December
UK-based charity International Health Partners says the value of donations to its latest ‘Big Give’ appeal will be doubled in early December, as it continues to work to provide healthcare access to people in disaster-hit and vulnerable communities.